Log In
BCIQ
Print this Print this
 

PR5i (DTP-HepB-Polio-Hib Pediatric hexavalent vaccine) (V419)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCombination vaccine against diphtheria, tetanus and pertussis (DTP), hepatitis B, polio and Haemophilus influenzae type B
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentRegistration
Standard IndicationBacterial infection
Indication DetailsVaccinate against DTP, hepatitis B, polio and Haemophilus influenzae type B; Vaccinate in children against DTP, hepatitis B, polio and Haemophilus influenzae type B
Regulatory Designation U.S. - Undisclosed Review (Vaccinate in children against DTP, hepatitis B, polio and Haemophilus influenzae type B)
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today